Astellas

Metallic arrow symbols which are illuminated by blue and magenta lights merge on blue and magenta b
Biotech

Astellas says 'I do' to Vir's T-cell engager in $1.7B deal

Vir is trading a stake in its PSMA-targeted bispecific VIR-5500 for a $335 million upfront and near-term capital infusion from Astellas.
Angus Liu Feb 23, 2026 5:00pm
Astellas
Favicon Fierce Pharma

Astellas lifts forecast as Vyloy surge counters trial miss

Feb 5, 2026 11:00am
Naoki Okamura
Favicon Fierce Pharma

Astellas CEO resists 'rescue BD' as Xtandi patent cliff nears

Jan 15, 2026 10:42am
eyeball

Ocugen update charts course for rivalry with Apellis, Astellas

Jan 15, 2026 9:22am
Silhouette of Businessman Entering Lit Door Passage in Darkness

Astellas turns down option to license Taysha gene therapy—again

Oct 17, 2025 10:50am
RNA Concept 3D Render

Japan biotech inks RNA research pact that includes mRNA compounds

Sep 19, 2025 10:49am